Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Sep;175(9):1332-1334.
doi: 10.7326/M22-2329. Epub 2022 Aug 16.

The Fast and the Furious: Chasing a Clinical Niche for COVID-19 Convalescent Plasma

Jason V Baker  1 , H Clifford Lane  2
Affiliations
Editorial

The Fast and the Furious: Chasing a Clinical Niche for COVID-19 Convalescent Plasma

Jason V Baker et al. Ann Intern Med. 2022 Sep.

Abstract

The Association for the Advancement of Blood and Biotherapies reported a thorough analysis of existing data and guidelines for the use of COVID-19 convalescent plasma (CCP) for treatment and prophylaxis of COVID-19. The editorialists discuss the recommendations, how they compare with recommendations from other entities, and the lessons the experience with CCP provides for the use of passive immunotherapy for future emerging infectious diseases.

PubMed Disclaimer

Conflict of interest statement

Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M22-2329.

Comment on

References

    1. Maiztegui JI , Fernandez NJ , de Damilano AJ . Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet. 1979;2:1216-7. [PMID: ] - PubMed
    1. Senefeld JW , Johnson PW , Kunze KL , et al. Access to and safety of COVID-19 convalescent plasma in the United States expanded access program: a national registry study. PLoS Med. 2021;18:e1003872. [PMID: ] doi: 10.1371/journal.pmed.1003872 - DOI - PMC - PubMed
    1. Estcourt LJ, Cohn CS, Pagano MB, et al. Clinical practice guidelines from the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 convalescent plasma. Ann Intern Med. 16 August 2022. [Epub ahead of print]. doi: 10.7326/M22-1079 - DOI - PMC - PubMed
    1. Bastard P , Rosen LB , Zhang Q , et al; HGID Lab. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370. [PMID: ] doi: 10.1126/science.abd4585 - DOI - PMC - PubMed
    1. Gupta A , Gonzalez-Rojas Y , Juarez E , et al; COMET-ICE Investigators. Effect of sotrovimab on hospitalization or death among high-risk patients with mild to moderate COVID-19: a randomized clinical trial. JAMA. 2022;327:1236-1246. [PMID: ] doi: 10.1001/jama.2022.2832 - DOI - PMC - PubMed